Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-07-29

FDA Approved: BROMFENAC — Original Application (Amneal Pharmaceuticals NY LLC)

View source ↗

Summary

The FDA approved Amneal Pharmaceuticals NY LLC's bromfenac as a generic under Original Application ANDA210962. Bromfenac is approved as an NSAID for relief of p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • BROMFENAC (Bromfenac)

Snippet

ORIG AP for BROMFENAC (BROMFENAC)